Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group

Date issued
2013Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso
